Qatari German Company for Medical Devices (Q.P.S.C.) Valuation

Is QGMD undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of QGMD when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate QGMD's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate QGMD's fair value for valuation analysis.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for QGMD?

Key metric: As QGMD is barely profitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for QGMD. This is calculated by dividing QGMD's market cap by their current revenue.
What is QGMD's PS Ratio?
PS Ratio	14x
Sales	ر.ق11.89m
Market Cap	ر.ق166.20m

QGMD key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	25.8x
Enterprise Value/EBITDA	221.1x
PEG Ratio	n/a

Price to Sales Ratio vs Peers

How does QGMD's PS Ratio compare to its peers?

The above table shows the PS ratio for QGMD vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PS	Estimated Growth	Market Cap
Peer Average	2.9x
ABDX Abingdon Health	4.6x	30.7%	UK£27.9m
8513 MaxWin International Holdings	4.6x	n/a	HK$233.3m
4735 AViTA	1.6x	n/a	NT$1.4b
A142280 Green Cross Medical Science	0.9x	n/a	₩82.1b
QGMD Qatari German Company for Medical Devices (Q.P.S.C.)	14x	n/a	ر.ق166.2m

Price-To-Sales vs Peers: QGMD is expensive based on its Price-To-Sales Ratio (14x) compared to the peer average (2.9x).

Price to Sales Ratio vs Industry

How does QGMD's PS Ratio compare vs other companies in the Asian Medical Equipment Industry?

30 Companies	Price / Sales	Estimated Growth	Market Cap

30 Companies		Estimated Growth	Market Cap

No more companies

Price-To-Sales vs Industry: QGMD is expensive based on its Price-To-Sales Ratio (14x) compared to the Asian Medical Equipment industry average (3.3x).

Price to Sales Ratio vs Fair Ratio

What is QGMD's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

QGMD PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio	14x
Fair PS Ratio	n/a

Price-To-Sales vs Fair Ratio: Insufficient data to calculate QGMD's Price-To-Sales Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.